Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 3, 2008, Pages 614-620

  Rock, Cheryl L ^a   Flatt, Shirley W ^a   Laughlin, Gail A ^a   Gold, Ellen B ^b   Thomson, Cynthia A ^c   Natarajan, Loki ^a   Jones, Lovell A ^d   Caan, Bette J ^e   Stefanick, Marcia L ^f   Hajek, Richard A ^d   Al Delaimy, Wael K ^a   Stanczyk, Frank Z ^g   Pierce, John P ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e DIVISION OF RESEARCH   (United States)

^f STANFORD CANCER INSTITUTE   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK;

EID: 41549122733     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0761     Document Type: Article

References (31)

1. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344:276-85.
2. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353-64.
3. Snekeker SM, Diaugustine R. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland. In: Huff J, Boyd J, Barrett JC, editors. Cellular and molecular mechanisms of hormonal carcinogenesis: environmental Influences. New York: Wiley-Liss; 1996.
4. Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
5. Endogenous Hormones and Breast Cancer Collaborative Group. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
6. Key TJ. Serum oestradiol and breast cancer risk. Endocr Relat Cancer 1999;6:175-80.
7. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 2003;349:1793-802.
8. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: an overview. Oncologist 2006;11:553-62.
9. Mourits MJE, De Vries EGE, Willemse PHB, Ten Hoor KA, Hollema H, Van der Zee AG. Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 2001;97:855-60.
10. Lum SS, Woltering EA, Fletcher WS, Pommier RF. Changes in serum estrogen levels in women during tamoxifen therapy. Am J Surg 1997;173:399-402.
11. Harper-Wynne CL, Sacks NPM, Shenton K, et al. Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer. J Clin Oncol 2002;20:1026-35.
12. Secreto G, Zumoff B. Paradoxical effects associated with supranormal urinary testosterone excretion in premenopausal women with breast cancer: increased risk of postmastectomy recurrence and higher remission rate after ovariectomy. Cancer Res 1983;43:3408-11.
13. Berrino F, Pasanisi P, Bellati C, et al. Serum testosterone levels and breast cancer recurrence. Int J Cancer 2005;113:499-502.
14. Pierce JP, Faerber S, Wright FA, et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials 2002;23:728-56.
15. Pierce JP, Natarajan L, Caan BJ, et al. The influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial. JAMA 2007;298:289-98.
16. American Joint Committee on Cancer. Manual for staging of cancer. 6th ed. New York: Springer-Verlag; 2002.
17. Langholz B, Thomas DC. Nested case-control and case-cohort methods of sampling from a cohort: a critical comparison. Am J Epidemiol 1990;131:169-76.
18. Lubin JH, Gail MH. Biometrics 1984. Biased selection of controls for case-control analyses of cohort studies. Biometrics 1984;40:63-75.
19. Rock CL, Flatt SW, Thomson CA, et al. Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 2004;22:2379-87.
20. Monroe KR, Murphy SP, Henderson BE, et al. Dietary fiber intake and endogenous serum hormone levels in naturally postmenopausal Mexican American women: the Multiethnic Cohort Study. Nutr Cancer 2007;58:127-35.
21. Holmes MD, Chen WY, Faskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86.
22. Pierce JP, Stefanick ML, Flatt SW, et al. Greater survival in physically active women with high vegetable-fruit intake regardless of obesity in breast cancer survivors. J Clin Oncol 2007;25:2345-51.
23. Johnson-Kozlow M, Rock CL, Gilpin EA, Hollenbach KA, Pierce JP. Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer. Am J Health Behav 2007;31:193-202.
24. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sport Exerc 2000;32:S498-504.
25. Mortimer JE, Flatt SW, Parker BA, et al. Tamoxifen, hot flashes and recurrence in breast cancer. Breast Cancer Res Treat 2007;10.1007/s10549-007- 9612-x.
26. Gold EB, Flatt SW, Pierce JP, et al. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 2006;13:423-33.
27. Abrahamson PE, Tworoger SS, Aiello EJ, et al. Associations between the CYP17, CYP1B1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors. Breast Cancer Res Treat 2007;10.1007/s10549-006-9426-2.
28. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801-10.
29. Beattie MS, Costantino JP, Cummings SR, et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). J Natl Cancer Inst 2006;98:110-5.
30. Micheli A, Meneghini E, Secreto G, et al. Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 2007;25:2685-90.
31. Art CJ, Govers CA, van den Berg H, et al. In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol 1991;38:621-8.